Primary thrombosis prevention in aPL-positive patients
- PMID: 18457613
- DOI: 10.1007/s11926-008-0010-0
Primary thrombosis prevention in aPL-positive patients
Comment on
-
Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals.Arthritis Rheum. 2007 Jul;56(7):2382-91. doi: 10.1002/art.22663. Arthritis Rheum. 2007. PMID: 17599766 Clinical Trial.